Effects of arsenic exposure on the frequency of HPRT-mutant lymphocytes in a population of copper roasters in Antofagasta, Chile: A pilot study

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 431, Issue 2, 1999, Pages 247-257

  Harrington Brock, Karen ^a   Cabrera, Marta ^b   Collard, Deborah D ^a   Doerr, Carolyn L ^a   McConnell, Rob ^c   Moore, Martha M ^a   Sandoval, Hernan ^d   Fuscoe, James C ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d Asociacion Chilena de Seguridad   (Chile)

Author keywords

Arsenic; Genotoxicity; HPRT; Human exposure; Mutagenesis

Indexed keywords

ARTICLE; CHILE; GENE FREQUENCY; GENE MUTATION; GENOTOXICITY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; OCCUPATIONAL TOXICOLOGY; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT;

AGED; ARSENIC; BIOLOGICAL MARKERS; CHILE; CHROMOSOME ABERRATIONS; DNA MUTATIONAL ANALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENETICS, POPULATION; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; LYMPHOCYTES; MALE; METALLURGY; MIDDLE AGED; MUTATION; OCCUPATIONAL EXPOSURE; PILOT PROJECTS;

EID: 0033386487     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(99)00167-0     Document Type: Article

References (35)

1. Some metals and metallic compounds. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. 23:1980;IARC, Lyon.
2. Arsenic and arsenic compounds. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. 7:1987;IARC, Lyon. Suppl.
3. Smith A.H., Goycolea M., Biggs M.L. Marked increase in bladder and lung cancer mortality in a region of northern Chile due to arsenic in drinking water. Am. J. Epidemiol. 147:1998;660-669.
4. Genetic and related effects. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. 6:1987;IARC, Lyon. Suppl.
5. Snow E.T. Metal carcinogenesis: mechanistic implications. Pharmacol. Ther. 53:1992;31-65.
6. Rossman T.G., Stone D., Molina M., Troll W. Absence of arsenite mutagenicity in E. coli and Chinese hamster cells. Environ. Mutagen. 2:1980;371-379.
7. Hei T.K., Liu S.X., Waldren C. Mutagenicity of arsenic in mammalian cells: role of reactive oxygen species. Proc. Natl. Acad. Sci. U.S.A. 95:1998;8103-8107.
8. Moore M.M., Harrington-Brock K., Doerr C.L. Relative genotoxic potency of arsenic and its methylated metabolites. Mutat. Res. 386:1997;279-290.
9. Jacobson-Kram D., Montalbano D. The reproductive effects assessment group's report on the mutagenicity of inorganic arsenic. Environ. Mutagen. 7:1985;787-804.
10. Wiencke J.K., Yager J.W. Specificity of arsenite in potentiating cytogenetic damage induced by the DNA crosslinking agent diepoxybutane. Environ. Mol. Mutagen. 19:1992;195-200.
11. Rasmussen R.E., Menzel D.B. Variation in arsenic-induced sister chromatid exchange in human lymphocytes and lymphoblastoid cell lines. Mutat. Res. 386:1997;299-306.
12. Gonsebatt M.E., Vega L., Salazar A.M., Montero R., Guzman P., Blas J., Del Razo L.M., Garcia-Vargas G., Albores A., Cebrian M.E., Kelsh M., Ostrosky-Wegman P. Cytogenetic effects in human exposure to arsenic. Mutat. Res. 386:1997;219-228.
13. Moore L.E., Smith A.H., Hopenhayn-Rich C., Biggs M.L., Kalman D.A., Smith M.T. Micronuclei in exfoliated bladder cells among individuals chronically exposed to arsenic in drinking water. Cancer Epidemiol., Biomarkers Prev. 6:1997;31-36.
14. Maki-Paakkanen J., Kurttio P., Paldy A., Pekkanen J. Association between the clastogenic effect in peripheral lymphocytes and human exposure to arsenic through drinking water. Environ. Mol. Mutagen. 32:1998;301-313.
15. Dulout F.N., Grillo C.A., Seoane A.I., Maderna C.R., Nilsson R., Vahter M., Darroudi F., Natarajan A.T. Chromosomal aberrations in peripheral blood lymphocytes from native Andean women and children from northwestern Argentina exposed to arsenic in drinking water. Mutat. Res. 370:1996;151-158.
16. Yang J.L., Chen M.F., Wu C.W., Lee T.C. Posttreatment with sodium arsenite alters the mutational spectrum induced by ultraviolet light irradiation in Chinese hamster ovary cells. Environ. Mol. Mutagen. 20:1992;156-164.
17. Jan K.Y., Huang R.Y., Lee T.C. Different modes of action of sodium arsenite, 3-aminobenzamide, and caffeine on the enhancement of ethyl methanesulfonate clastogenicity. Cytogenet. Cell Genet. 41:1986;202-208.
18. Vahter M., Concha G., Nermell B., Nilsson R., Dulout F., Natarajan A.T. A unique metabolism of inorganic arsenic in native Andean women. Eur. J. Pharmacol. 293:1995;455-462.
19. US EPA, Special report on ingested arsenic, EPA/625/3-87/013, Risk Assessment Forum, US Environmental Protection Agency, Washington, DC, 1988.
20. Tseng W.P., Chu H.M., How S.W., Fong J.M., Lin C.S., Yeh S. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J. Natl. Cancer Inst. 40:1968;453-463.
21. Kempic J.B. Arsenic removal technologies: an evaluation of cost and performance. Abernathy C.O., Calderon R.L., Chappell W.R. Arsenic. 1997;393-405 Chapman and Hall, London.
22. Buratti M., Calzaferri G., Caravelli G., Colombi A., Maroni M., Foa V. Significance of arsenic metabolic forms in urine: Part I. Chemical speciation. Int. J. Environ. Anal. Chem. 17:1984;25-34.
23. Moore M.M., Harrington-Brock K., Zimmerman L.J., Burnette L.P., Smith T.W., Everson R.B., O'Neill J.P., Fuscoe J.C. Quantification and molecular characterization of HPRT mutants of human T-lymphocytes. Environ. Health Perspect. 101(Suppl. 3):1993;219-224.
24. Gibbs R.A., Nguyen P.N., Edwards A., Civitello A.B., Caskey C.T. Multiplex DNA deletion detection and exon sequencing of the hypoxanthine phosphoribosyltransferase gene in Lesch-Nyhan families. Genomics. 7:1990;235-244.
25. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning, A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
26. Fuscoe J.C., Zimmerman L.J., Harrington-Brock K., Moore M.M. Large deletions are tolerated at the HPRT locus of in vivo derived human T-lymphocytes. Mutat. Res. 283:1992;255-262.
27. Cole J., Skopek T.R. Somatic mutant frequency, mutation rates and mutational spectra in the human population in vivo. Mutat. Res. 304:1994;33-105.
28. Fuscoe J.C., Zimmerman L.J., Harrington-Brock K., Moore M.M. Multiplex PCR analysis of in vivo-arising deletion mutations in the HPRT gene of human T-lymphocytes. Environ. Mol. Mutagen. 23:1994;89-95.
29. Albertini R.J., Nicklas J.A., O'Neill J.P. Somatic cell gene mutations in humans: biomarkers for genotoxicity. Environ. Health Perspect. 101(Suppl. 3):1993;193-201.
30. Fuscoe J.C., Nelsen A.J., Pilia G. Detection of deletion mutations extending beyond the HPRT gene by multiplex PCR analysis. Somatic Cell Mol. Genet. 20:1994;39-46.
31. Lippert M.J., Nicklas J.A., Hunter T.C., Albertini R.J. Pulsed field analysis of HPRT T-cell large deletions: telomeric region breakpoint spectrum. Mutat. Res. 326:1995;51-64.
32. Fuscoe J.C., Zimmerman L.J., Lippert M.J., Nicklas J.A., O'Neill J.P., Albertini R.J. V(D)J recombinase-like activity mediates HPRT gene deletion in human fetal T-lymphocytes. Cancer Res. 51:1991;6001-6005.
33. Fuscoe J.C., Zimmerman L.J., Harrington-Brock K., Burnette L., Moore M.M., Nicklas J.A., O'Neill J.P., Albertini R.J. V(D)J recombinase-mediated deletion of the HPRT gene in T-lymphocytes from adult humans. Mutat. Res. 283:1992;13-20.
34. Ostrosky-Wegman P., Gonsebatt M.E., Montero R., Vega L., Barba H., Espinosa J., Palao A., Cortinas C., Garcia-Vargas G., del Razo L.M.et al. Lymphocyte proliferation kinetics and genotoxic findings in a pilot study on individuals chronically exposed to arsenic in Mexico. Mutat. Res. 250:1991;477-482.
35. Concha G., Nermell B., Vahter M.V. Metabolism of inorganic arsenic in children with chronic high arsenic exposure in northern Argentina. Environ. Health Perspect. 106:1998;355-359.